ArticleMicrobial cell factories2025
Green synthesis of silver nanoparticles (AgNPs) from G. stearothermophilus GF16: stable and versatile nanomaterials with antioxidant, antimicrobial, and catalytic properties.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Silver quantum dots in plasmonic photocatalysis: linking quantum confinement to structure-function relationships.RSC advances · 2026Review
- Postbiotic-Mediated Green Synthesis of Silver Nanoparticles: Revealing Potent Antimicrobial, Anti-Biofilm, Antioxidant, and Anticancer Properties using Paenibacillus xylanexedens.Probiotics and antimicrobial proteins · 2026Article
- Silver Nanoparticles in Antibacterial Research: Mechanisms, Applications, and Emerging Perspectives.International journal of molecular sciences · 2026Review
- Silver nanoparticles fabricated using phycocyanin from Arthrospira platensis: green synthesis, physicochemical characterization, and biological activities.Microbial cell factories · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSilver nanoparticles (AgNPs) have attracted considerable interest for their distinctive physicochemical properties and wide-ranging applications in nanomedicine, environmental catalysis, and antimicrobial applications. However, sustainable and robust biosynthesis methods remain a challenge.
resultsIn this study, we report the biosynthesis of thermostable AgNPs using the secretome of Geobacillus stearothermophilus GF16, a thermophilic and metal-resistant bacterium isolated from the hydrothermal volcanic area of Pisciarelli, Italy. The synthesis was performed without specialized growth media, relying solely on the cell-free bacterial supernatant, and was systematically optimized by varying precursor concentration, temperature, pH, and reaction time. The nanoparticles were characterized by UV-Vis spectroscopy, dynamic light scattering, Fourier-transform infrared spectroscopy, scanning (SEM) and transmission (TEM) electron microscopy. Morphological analysis showed predominantly subspherical nanoparticles with average diameters of 17 ± 5 nm (SEM) and 16 ± 5-7 nm (TEM), depending on precursor concentration. Thermogravimetric analysis demonstrated excellent thermal stability with retention of structural integrity up to 120 °C, an exceptional feature among biogenic AgNPs. The obtained AgNPs exhibited remarkable radical scavenging activity, reaching up to 79% in DPPH and 75% in ABTS assays at 100 µg/mL, highlighting a level of antioxidant performance rarely observed in AgNPs of bacterial origin. In addition to their redox properties, the nanoparticles demonstrated efficient catalytic activity as evidenced by the complete degradation of Congo Red in 20 min and 4-nitrophenol in 35 min. Time-kill assays and minimum inhibitory concentration (MIC) also showed a broad-spectrum antimicrobial potential with complete inhibition of Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella Typhimurium at 100 µg/mL. Interestingly, MIC values were significantly lower than those reported for comparable AgNPs. Notably, the nanoparticles also displayed hemocompatibility, validated by hemolysis assays performed on both healthy and β-thalassemic erythrocytes, with hemolysis rates consistently below the 2% safety threshold.
conclusionsOverall, this study presents the first comprehensive characterization of AgNPs biosynthesized by a thermophilic bacterium, highlighting their multifunctional potential. The use of a thermophilic bacterium as a robust and flexible microbial nanofactory offers a novel eco-friendly and scalable strategy for AgNP production. The resulting nanoparticles exhibit unique thermal stability, broad-spectrum bioactivity, and clinically relevant hemocompatibility, underscoring their promising applicability in nanomedicine, green catalysis, and environmental remediation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.